Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D5T3OY
|
|||
| Drug Name |
DPX Survivac
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Diffuse large B-cell lymphoma [ICD-11: 2A81; ICD-10: C83.3; ICD-9: 200] | Phase 2 | [1] | |
| Company |
Immunovaccine
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02323230) A Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCL. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.